Personalized Therapy of Chronic Hepatitis C and B Dually Infected Patients With Pegylated Interferon Plus Ribavirin: A Randomized Study

por Yeh, Ming-Lun, Hsieh, Ming-Yen, Huang, Ching-I., Huang, Chung-Feng, Hsieh, Meng-Hsuan, Liang, Po-Cheng, Lin, Yi-Hung, Hou, Nai-Jen, Lin, Zu-Yau, Chen, Shinn-Cherng, Huang, Jee-Fu, Dai, Chia-Yen, Chuang, Wan-Long, Yu, Ming-Lung
Publicado 2015

Elevated on-treatment levels of serum IFN-gamma is associated with treatment failure of peginterferon plus ribavirin therapy for chronic hepatitis C

por Lu, Ming-Ying, Huang, Ching-I, Dai, Chia-Yen, Wang, Shu-Chi, Hsieh, Ming-Yen, Hsieh, Meng-Hsuan, Liang, Po-Cheng, Lin, Yi-Hung, Hou, Nai-Jen, Yeh, Ming-Lun, Huang, Chung-Feng, Lin, Zu-Yau, Chen, Shinn-Cherng, Huang, Jee-Fu, Chuang, Wan-Long, Yu, Ming-Lung
Publicado 2016

Huge Gap Between Clinical Efficacy and Community Effectiveness in the Treatment of Chronic Hepatitis C: A Nationwide Survey in Taiwan

por Yu, Ming-Lung, Yeh, Ming-Lun, Tsai, Pei-Chien, Huang, Ching-I., Huang, Jee-Fu, Huang, Chung-Feng, Hsieh, Meng-Hsuan, Liang, Po-Cheng, Lin, Yi-Hung, Hsieh, Ming-Yen, Lin, Wen-Yi, Hou, Nai-Jen, Lin, Zu-Yau, Chen, Shinn-Cherng, Dai, Chia-Yen, Chuang, Wan-Long, Chang, Wen-Yu
Publicado 2015

Dynamics of PBMC gene expression in hepatitis C virus genotype 1-infected patients during combined peginterferon/ribavirin therapy

por Lu, Ming-Ying, Huang, Ching-I, Hsieh, Ming-Yen, Hsieh, Tusty-Juan, Hsi, Edward, Tsai, Pei-Chien, Tsai, Yi-Shan, Lin, Ching-Chih, Hsieh, Meng-Hsuan, Liang, Po-Cheng, Lin, Yi-Hung, Hou, Nai-Jen, Yeh, Ming-Lun, Huang, Chung-Feng, Lin, Zu-Yau, Chen, Shinn-Cherng, Huang, Jee-Fu, Chuang, Wan-Long, Dai, Chia-Yen, Yu, Ming-Lung
Publicado 2016

Identification of groups with poor cost-effectiveness of peginterferon plus ribavirin for naïve hepatitis C patients with a real-world cohort and database

por Tsai, Pei-Chien, Liu, Ta-Wei, Tsai, Yi-Shan, Ko, Yu-Min, Chen, Kuan-Yu, Lin, Ching-Chih, Huang, Ching-I, Liang, Po-Cheng, Lin, Yi-Hung, Hsieh, Ming-Yen, Hou, Nai-Jen, Huang, Chung-Feng, Yeh, Ming-Lun, Lin, Zu-Yau, Chen, Shinn-Cherng, Dai, Chia-Yen, Chuang, Wan-Long, Huang, Jee-Fu, Yu, Ming-Lung
Publicado 2017

Concordance of SVR12, SVR24 and SVR durability in Taiwanese chronic hepatitis C patients with direct-acting antivirals

por Lin, Chuan-Pin, Liang, Po-Cheng, Huang, Ching-I, Yeh, Ming-Lun, Hsu, Po-Yao, Hsu, Cheng-Ting, Wei, Yu-Ju, Liu, Ta-Wei, Hsieh, Ming-Yen, Hou, Nai-Jen, Jang, Tyng-Yuang, Lin, Yi-Hung, Wang, Chih-Wen, Lin, Zu-Yau, Chen, Shinn-Cherng, Huang, Chung-Feng, Huang, Jee-Fu, Dai, Chia-Yen, Chuang, Wan-Long, Yu, Ming-Lung
Publicado 2021

Regorafenib for Taiwanese patients with unresectable hepatocellular carcinoma after sorafenib failure: Impact of alpha‐fetoprotein levels

por Hsu, Po‐Yao, Cheng, Tzu‐Sheng, Chuang, Shih‐Chang, Chang, Wen‐Tsan, Liang, Po‐Cheng, Hsu, Cheng‐Ting, Wei, Yu‐Ju, Jang, Tyng‐Yuan, Yeh, Ming‐Lun, Huang, Ching‐I, Lin, Yi‐Hung, Wang, Chih‐Wen, Hsieh, Ming‐Yen, Hou, Nai‐Jen, Hsieh, Meng‐Hsuan, Tsai, Yi‐Shan, Ko, Yu‐Min, Lin, Ching‐Chih, Chen, Kuan‐Yu, Dai, Chia‐Yen, Lin, Zu‐Yau, Chen, Shinn‐Cherng, Huang, Jee‐Fu, Chuang, Wan‐Long, Huang, Chung‐Feng, Yu, Ming‐Lung
Publicado 2021